Pliant Therapeutics, Inc. (PLRX) Tops Q3 EPS by 2c

Pliant Therapeutics, Inc. (NASDAQ: PLRX) reported Q3 EPS of ($0.95), $0.02 better than the analyst estimate of ($0.97).

For earnings history and earnings-related data on Pliant Therapeutics, Inc. (PLRX) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• MIND Technology (MIND) Misses Q1 EPS by 5c
• 51Talk Online Education Group (COE) Reports Q1 EPS of $0.00